Evogene (EVGN) Reports Q2 Loss of $0.31, Revenues Miss

July 31, 2019 7:22 AM

Evogene (NASDAQ: EVGN) reported Q2 EPS of ($0.31), versus ($0.39) reported last year. Revenue for the quarter came in at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found